Brief: Hansa Biopharma Q1 Net Income SEK -37.1 Million
24/04/2025 07:00
Apr 24 (Reuters) - Hansa Biopharma Q1 EBIT SEK -93.4 million. Q1 revenue SEK 66.3 million Q1 cash & investments SEK 250.2 million Q1 adjusted EPS SEK -0.55
Recent news on Hansa Biopharma AB
See all newsBrief: Hansa Biopharma Q3 Rev Up At SEK 143 Mln
Sweden's Hansa Biopharma Q3 revenue surges on SERB license deal
Brief: Hansa Biopharma Q3 Net Income SEK -178.5 Million
Brief: Hansa Biopharma Announces Positive Idefirix Paes Results Presented In The High-Impact Clinical Trials Session At Asn Kidney Week
Brief: Hansa Biopharma Submits IND Application To FDA For HNSA-5487 In GBS